The underwriting of cerebrovascular disease very often has as its basis an overall assessment of the proposed insured’s cardiovascular profile combined with characteristics of the stroke itself. Read More

Life insurance can be a powerful, cost-effective tool in wealth and estate planning solutions, and HNW and mass affluent markets represent a broadening range of opportunities for product development and the provision of value-added services. Read More

This brief explains hepatitis C, discusses the new drugs and their efficacy, and provides guidance around verification of medical necessity of treatment, claims considerations and underwriting considerations. Read More

Underwriters need to act now to monitor and prepare for rapid technological changes in information access and management.  Read More

This report aims to show how primary life insurers can explore or strengthen their existing presence in this brokered international market by developing successful strategies that can optimize market presence and penetration. Read More

RGA shares three general principles and 12 case studies that summarize our many experiences, observations, and conclusions around Solvency II.  Read More

This article seeks to unbundle the factors giving rise to, or perpetuating, the division between claims and rehabilitation professionals, who by the very nature of claims management should be close bedfellows.  Read More

RGA discusses Electronic Health Records with respect to life insurance, current initiatives, and strategies for data utilization.

Read More

In a world where “busy-ness” rules, are there places where we could bridge this gap? Read More

Although the insurance industry may not be perceived as the nexus of technological innovation, the influence of technology on insurers is profound and a technology and data analytics race is already well underway. This article explores these implications.  Read More

A two-part look at three more biomarkers:  p2PSA, red cell distribution width (RDW) and cystatin C. Read More

This article explores general guidelines associated with pediatric underwriting, including:

• Parent or parents should have insurance on their own lives of at least two times the amount of insurance of the&...

Read More

Developed countries experience high levels of asthma, chronic obstructive pulmonary disease (COPD) and lung cancer³. In developing countries, major problems include tuberculosis (TB) and other respiratory system infections. RGA evaluates the...

Read More

This article explores the medical underwriting implications of sports injury hospitalisations. Sporting activities can lead to a range of injuries requiring hospitalisation and potential short- or long-term disablement.  Read More

Electronic cigarettes are rapidly growing in popularity and may even eclipse traditional
cigarettes in the future, barring any restrictive regulations. This article examines underwriting considerations.  Read More

This article presents challenges and opportunities in applying predictive modeling to group reinsurance and insurance. For a deeper look at this topic, please see:  Read More

This research compares capabilities of emerging wearable health and fitness devices and evaluates insurance implications. Read More

Longevity product innovations have been attempted in Australia, and RGA's Patrick Reen believes there are more opportunities in Australia’s retirement income market. This article evaluates improved member guidance as well as richer product offerings for the superannuati... Read More

This article summarizes RGA's Claims Management Pathway (CMP), which assists in implementing change and raising disability claims management standards across the Australian industry Read More